Navigation Links
3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012

SHENYANG, China, May 1, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has filed the Company's Annual Report on Form 20-F for the fiscal year ended December 31, 2012 with the U.S. Security and Exchange Commission on April 30, 2013. The annual report on Form 20-F, which contains its audited financial statements, can be accessed on the SEC's website at or on the Investor section of the Company's website Shareholders may also receive a hard copy of the annual report free of charge upon request.

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China.  Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.  With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see for more information.

Investor Contacts

Bo Tan
Chief Financial Officer
3SBio Inc.
Tel: + 86 24 2581-1820  

Tom Folinsbee
Director of Investor Relations
3SBio Inc.
Tel: + 852 8191-6991

Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. 3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders
2. 3SBio Inc. Enters Into Merger Agreement For "Going Private" Transaction
3. 3SBio Inc. Announces Unaudited First Quarter 2012 Results
4. 3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2011
5. 3SBio Inc. to Present at the UBS Greater China Conference 2012
6. Early Stage Drug Delivery Technologies: 62 Profiles of Start-ups and Emerging Companies
7. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
8. TNI BioTech Files Form 10 with SEC
9. Marrone Bio Innovations Files Patent for a Unique Bacillus Species
10. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
11. NDIS Approval of the Promega PowerPlex(R) Y23 System Enables More Usable Profiles in Less Time
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015  ATCC, the premier ... that it has been selected by The Michael J. ... cell lines to academic, pharmaceutical, and biotechnology organizations committed ... the United States , and more ... the United States , and more ...
(Date:10/8/2015)... Texas , Oct. 8, 2015 The 2015 ... of The University of Texas at Dallas. Aziz Sancar ... UT Dallas in 1977, is one of ... how cells continuously monitor and repair damaged DNA on a molecular ... in molecular and cell biology from UT Dallas ...
(Date:10/8/2015)... ST. LOUIS , Oct. 8, 2015 /PRNewswire/ ... that the Cerilliant ® brand within its ... its new bile acid reference standards product line ... the most routinely tested bile acids and their ... materials (CRMs) consist of lithocholic acid, taurocholic acid ...
(Date:10/7/2015)... , Oct. 7, 2015 Boston Scientific ... start of the Boston Scientific Connected Patient Challenge ... in the use of remote patient monitoring to enhance ... and entrepreneurs can submit their ideas and collaborate on ... ). Cambridge, MA ...
Breaking Biology Technology:
... 2011 At the White House today, President Barack ... U.S. recipients of the 2010 Kavli Prizes to recognize ... for which the Prizes are awarded -- astrophysics, nanoscience ... Joined by the President,s science advisor, John ...
... Kingdom, June 6, 2011 Oxford BioMedicaplc ... gene therapy company, today announces that it has signed ... biotechnology company specialising in the development of engineered antibody ... engineer an in vivo diagnostic imaging agent ...
... Biosciences, a leading innovator in protein diagnostics, announces ... allows researchers to cost effectively accelerate their research ... Avantra,s proven QPDx™ BioChip platform. The QPDx™ platform ... using catalog or custom reagents. Avantra,s ...
Cached Biology Technology:
(Date:9/10/2015)... , Sept. 10, 2015 Report Details ... far not quite delivered upon previous expectations of revenues, ... be the breakthrough year in which wearables begin to ... expected. One of the main reasons is the entrance ... not only the SmartWatches market, but the overall size ...
(Date:9/8/2015)... 8, 2015   TREW Marketing and ... Smart Marketing for Engineers TM : Content and ... reveals insightful findings about engineers, preferences for online content ... engineers most value and trust, and where they look ... technical audiences grapple with how to best implement online ...
(Date:9/2/2015)... September 2, 2015 ... implied in a system which uses identical human ... iris, vein, DNA and finger print. Increasing number ... develop such system which provides high level of ... Patterns and tokens are vulnerable to attacks. Furthermore, ...
Breaking Biology News(10 mins):
... blueprint of the rock pigeon, unlocking secrets about pigeons, Middle ... how mutations give pigeons traits like feather head crests. ... we know surprisingly little about their genetics," says Michael Shapiro, ... at the University of Utah. In the new study, ...
... and NEWTOWN, Pa., Jan. 31, 2013   Shareholder ... the acquisition of BioClinica, Inc. (NASDAQ: BIOC ... solutions to pharmaceutical, biotechnology, and medical device companies. ... On January 30, 2013, BioClinica announced that it had ...
... On January 30, 2013 ACS Nano published ... in the division of biomedical engineering at Brigham and ... that utilize nanotechnology to enhance the conductivity of materials ... cardiac patches put medicine a step closer to durable, ...
Cached Biology News:
... Blunt TOPO PCR Cloning ... designed for cloning and ... PCR products. The pCR4Blunt-TOPO ... Cloning and greater than ...
... 5 ml CELLection Dynabeads (4.5 m) coated ... epithelial antigen EpCAM and DNase Releasing Buffer. ... of epithelial tumour cells directly from blood, ... can be enriched from bone marrow. Enriched ...
Recombinant Human CCL21/6Ckine (Mucin Stalk Chimera)...
Recombinant Human Erythropoietin (Tissue Culture Grade)...
Biology Products: